Timo Minssen is Professor of Biotechnology Law at the University of Copenhagen's Centre for Information & Innovation Law (CIIR), specializing in legal aspects of biomedical innovation. In 2016 he has been appointed as Visiting Research Fellow at the University of Cambridge. Before that, Timo has been Visiting Research Fellow at the University of Oxford, Harvard Law School, the Max Planck Institute for Innovation & Competition, and at the Chicago-Kent College of Law. He holds a German law degree from the University of Göttingen and Swedish LL.D. (Jur. Dr.) and LL.M. degrees from the Universities of Uppsala & Lund. Timo also worked for life science companies, the EPO, international law firms, and conducted studies in epigenetics at the Pufendorf Institute for Advanced Studies in Lund. He is co- leading the Copenhagen Biotech & Pharma Forum and heads legal WPs in 4 interdisciplinary pharma- and biotech- related research projects, including inter-faculty projects in Synthetic Biology, Biobanking and legal aspects of large European research infrastructures, such as the European Spallation Source and Synchrotron Radiation Facilities. He has published more than 50 peer-reviewed research articles in internationally renowned journals and was awarded the Swedish King Oscar stipendium for his book “Assessing the Inventiveness of Biopharmaceuticals under European and US Patent Law” (2012).
Visit Timo Minssen's research homepage at: